Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Surgical Endoscopy
Published in: Surgical Endoscopy 10/2013

01-10-2013

Impact of transoral incisionless fundoplication (TIF) on subjective and objective GERD indices: a systematic review of the published literature

Authors: Mark R. Wendling, W. Scott Melvin, Kyle A. Perry

Published in: Surgical Endoscopy | Issue 10/2013

Login to get access

Abstract

Background

Gastroesophageal reflux disease (GERD) remains a significant problem for the medical community. Many endoluminal treatments for GERD have been developed with little success. Currently, transoral incisionless fundoplication (TIF) attempts to recreate a surgical fundoplication through placement of full-thickness polypropylene H-fasteners. This, the most recent procedure to gain FDA approval, has shown some promise in the early data. However, questions of its safety profile, efficacy, and durability remain.

Methods

The Cochrane Library and MEDLINE through PubMed were searched to identify published studies reporting on subjective and objective GERD indices after TIF. The search was limited to human studies published in English from 2006 up to March 2012. Data collected included GERD-HRQL and RSI scores, PPI discontinuation and patient satisfaction rates, pH study metrics, complications, and treatment failures. Statistical analysis was performed with weighted t tests.

Results

Titles and abstracts of 214 papers were initially reviewed. Fifteen studies were found to be eligible, reporting on over 550 procedures. Both GERD-HRQL scores (21.9 vs. 5.9, p < 0.0001) and RSI scores (24.5 vs. 5.4, p ≤ 0.0001) were significantly reduced after TIF. Overall patient satisfaction was 72 %. The overall rate of PPI discontinuation was 67 % across all studies, with a mean follow-up of 8.3 months. pH metrics were not consistently normalized. The major complication rate was 3.2 % and the failure rate was 7.2 % across all studies.

Conclusion

TIF appears to provide symptomatic relief with reasonable levels of patient satisfaction at short-term follow-up. A well-designed prospective clinical trial is needed to assess the effectiveness and durability of TIF as well as to identify the patient population that will benefit from this procedure.
Literature
1.
American Gastroenterological Association (2001) The Burden of gastrointestinal diseases. AGA, Bethesda, pp 18–21
2.
Moayyedi P, Leontiadis GI (2012) The risks of PPI therapy. Nat Rev Gastroenterol Hepatol 9:132–139PubMedCrossRef
3.
Linsky A, Gupta K, Lawler EV et al (2010) Proton pump inhibitors and risk for recurrent Clostridium difficile infection. Arch Intern Med 170:772–778PubMedCrossRef
4.
Howell MD, Novack V, Grgurich P et al (2010) Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection. Arch Intern Med 170:784–790PubMedCrossRef
5.
Spechler SJ (1992) Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. The Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group. N Engl J Med 326:786–792PubMedCrossRef
6.
Finks JF, Wei Y, Birkmeyer JD (2006) The rise and fall of antireflux surgery in the United States. Surg Endosc 20:1698–1701PubMedCrossRef
7.
Barnes WE, Hoddinott KM, Mundy S et al (2011) Transoral incisionless fundoplication offers high patient satisfaction and relief of therapy-resistant typical and atypical symptoms of GERD in community practice. Surg Innov 18:119–129PubMedCrossRef
8.
Bell RC, Freeman KD (2011) Clinical and pH-metric outcomes of transoral esophagogastric fundoplication for the treatment of gastroesophageal reflux disease. Surg Endosc 25:1975–1984PubMedCrossRef
9.
Cadiere GB, Buset M, Muls V et al (2008) Antireflux transoral incisionless fundoplication using EsophyX: 12-month results of a prospective multicenter study. World J Surg 32:1676–1688PubMedCrossRef
10.
Cadiere GB, Van Sante N, Graves JE et al (2009) Two-year results of a feasibility study on antireflux transoral incisionless fundoplication using EsophyX. Surg Endosc 23:957–964PubMedCrossRef
11.
Demyttenaere SV, Bergman S, Pham T et al (2010) Transoral incisionless fundoplication for gastroesophageal reflux disease in an unselected patient population. Surg Endosc 24:854–858PubMedCrossRef
12.
Frazzoni M, Conigliaro R, Manta R et al (2011) Reflux parameters as modified by EsophyX or laparoscopic fundoplication in refractory GERD. Aliment Pharmacol Ther 34:67–75PubMedCrossRef
13.
Hoppo T, Immanuel A, Schuchert M et al (2010) Transoral incisionless fundoplication 2.0 procedure using EsophyX for gastroesophageal reflux disease. J Gastrointest Surg 14:1895–1901PubMedCrossRef
14.
Ihde GM, Besancon K, Deljkich E (2011) Short-term safety and symptomatic outcomes of transoral incisionless fundoplication with or without hiatal hernia repair in patients with chronic gastroesophageal reflux disease. Am J Surg 202:740–746 discussion 746–747PubMedCrossRef
15.
Narsule CK, Burch MA, Ebright MI et al (2012) Endoscopic fundoplication for the treatment of gastroesophageal reflux disease: initial experience. J Thorac Cardiovasc Surg 143:228–234PubMedCrossRef
16.
Nguyen A, Vo T, Nguyen XM et al (2011) Transoral incisionless fundoplication: initial experience in patients referred to an integrated academic institution. Am Surg 77:1386–1389PubMed
17.
Petersen RP, Filippa L, Wassenaar EB et al (2012) Comprehensive evaluation of endoscopic fundoplication using the EsophyX™ device. Surg Endosc 26(4):1021–1027PubMedCrossRef
18.
Repici A, Fumagalli U, Malesci A et al (2010) Endoluminal fundoplication (ELF) for GERD using EsophyX: a 12-month follow-up in a single-center experience. J Gastrointest Surg 14:1–6PubMedCrossRef
19.
Testoni PA, Vailati C, Testoni S et al (2012) Transoral incisionless fundoplication (TIF 2.0) with EsophyX for gastroesophageal reflux disease: long-term results and findings affecting outcome. Surg Endosc 26(5):1425–1435PubMedCrossRef
20.
Trad KS, Turgeon DG, Deljkich E (2012) Long-term outcomes after transoral incisionless fundoplication in patients with GERD and LPR symptoms. Surg Endosc 26:650–660PubMedCrossRef
21.
Velanovich V (2010) Endoscopic, endoluminal fundoplication for gastroesophageal reflux disease: initial experience and lessons learned. Surgery 148:646–651 discussion 651-643PubMedCrossRef
22.
Hunter J, Trus T, Branum G et al (1996) A physiologic approach to laparoscopic fundoplication for gastroesophageal reflux disease. Ann Surg 223:673–685PubMedCrossRef
23.
Testoni PA, Corsetti M, Di Pietro S et al (2010) Effect of transoral incisionless fundoplication on symptoms, PPI use, and pH-impedance refluxes of GERD patients. World J Surg 34:750–757PubMedCrossRef
24.
Khajanchee YS, Ujiki M, Dunst CM et al (2009) Patient factors predictive of 24-h pH normalization following endoluminal gastroplication for GERD. Surg Endosc 23:2525–2530PubMedCrossRef
25.
Bergman S, Mikami DJ, Hazey JW et al (2008) Endolumenal fundoplication with EsophyX: the initial North American experience. Surg Innov 15:166–170PubMedCrossRef
26.
Rantanen TK, Salo JA, Sipponen JT (1999) Fatal and life-threatening complications in antireflux surgery: analysis of 5,502 operations. Br J Surg 86:1573–1577PubMedCrossRef
27.
Bell RC, Cadiere GB (2011) Transoral rotational esophagogastric fundoplication: technical, anatomical, and safety considerations. Surg Endosc 25:2387–2399PubMedCrossRef
Metadata
Title
Impact of transoral incisionless fundoplication (TIF) on subjective and objective GERD indices: a systematic review of the published literature
Authors
Mark R. Wendling
W. Scott Melvin
Kyle A. Perry
Publication date
01-10-2013
Publisher
Springer US
Published in
Surgical Endoscopy / Issue 10/2013
Print ISSN: 0930-2794
Electronic ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-013-2961-0

Other articles of this Issue 10/2013

Surgical Endoscopy 10/2013 Go to the issue

OriginalPaper

Clinical implication of endoscopic gross appearance in early gastric cancer: revisited

OriginalPaper

Real-time near-infrared fluorescent cholangiography could shorten operative time during robotic single-site cholecystectomy

OriginalPaper

Pilot study evaluating the efficacy of AlloMEM™ for prevention of intraperitoneal adhesions and peritoneal regeneration after loop ileostomy

Dynamic Manuscript

Endoscopic ultrasound (EUS)-guided fiducial placement allows localization of small neuroendocrine tumors during parenchymal-sparing pancreatic surgery

Review

The Fellowship Council: a decade of impact on surgical training

OriginalPaper

TEP under general anesthesia is superior to Lichtenstein under local anesthesia in terms of pain 6 weeks after surgery: results from a randomized clinical trial